Our results highlight the potential utility of CNA investigation in single CTCs to portray the heterogeneous resistance landscape to ALK-TKIs and identify potentially targetable alternate bypass pathways in ALK-positive NSCLC patients. Here, ALK is linked to non-small cell lung carcinoma.